A Multicenter, Adaptive, Randomized, Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for Hospitalized Patients with COVID-19

Administered By

Awarded By

Contributors

Start/End

  • June 1, 2020 - May 31, 2022